Indication

For the treatment of adults infected with human immunodeficiency virus 1 (HIV-1) without past or present evidence of resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, lamivudine, or tenofovir.

Medicine details

Medicine name:
doravirine/lamivudine/tenofovir disoproxil fumarate (Delstrigo)
SMC ID:
SMC2333
Pharmaceutical company
Merck Sharp & Dohme Ltd
BNF chapter
Infections
Submission type
Abbreviated
Publication due date:
08 March 2021